NCT07558733: An ongoing trial by Faeth Therapeutics
This trial is ongoing. It must report results 3 years, 9 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07558733 |
|---|---|
| Title | Open-Label Umbrella Study to Evaluate Safety and Efficacy of Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced or Metastatic Breast Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 22, 2026 |
| Completion date | May 31, 2029 |
| Required reporting date | May 31, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Aug. 11, 2026 |
| Days late | None |